37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Investigation of a Large Collection of Pseudomonas aeruginosa Bacteriophages Collected from a Single Environmental Source in Abidjan, Côte d’Ivoire

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Twenty two distinct bacteriophages were isolated from sewage water from five locations in the city of Abidjan, Côte d'Ivoire over a two-year period, using a collection of Pseudomonas aeruginosa strains with diverse genotypes. The phages were characterized by their virulence spectrum on a panel of selected P. aeruginosa strains from cystic fibrosis patients and by whole genome sequencing. Twelve virions representing the observed diversity were visualised by electron microscopy. The combined observations showed that 17 phages, distributed into seven genera, were virulent, and that five phages were related to temperate phages belonging to three genera. Some showed similarity with known phages only at the protein level. The vast majority of the genetic variations among virulent phages from the same genus resulted from seemingly non-random horizontal transfer events, inside a population of P. aeruginosa phages with limited diversity. This suggests the existence of a single environmental reservoir or ecotype in which continuous selection is taking place. In contrast, mostly point mutations were observed among phages potentially capable of lysogenisation. This is the first study of P. aeruginosa phage diversity in an African city and it shows that a large variety of phage species can be recovered in a limited geographical site at least when different bacterial strains are used. The relative temporal and spatial stability of the Abidjan phage population might reflect equilibrium in the microbial community from which they are released.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.

          Pseudomonas aeruginosa is an ubiquitous pathogen capable of infecting virtually all tissues. A large variety of virulence factors contribute to its importance in burn wounds, lung infection and eye infection. Prominent factors include pili, flagella, lipopolysaccharide, proteases, quorum sensing, exotoxin A and exoenzymes secreted by the type III secretion system.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Bacteriophages and their genomes.

            Bacteriophages occupy a unique position in biology, representing an absolute majority of all organisms in the biosphere. Because their genomes are relatively small, elucidating the genetic diversity of the phage population, deciphering their origins, and identifying the evolutionary mechanisms that shape the population would seem readily feasible. And yet the pace of phage genome characterization has slowed over the past three years, reflecting in part a need to transition from sequencing known and well-characterized bacteriophages to the isolation and comparative analysis of new isolates. The current state of bacteriophage genomics shows that the genetic diversity of the population is very high, that phages have been actively evolving for billions of years with active engagement of horizontal genetic exchange, and that their genomes are consequently pervasively mosaic in their architectures. But we have barely scratched the surface and the next years of phage genome exploration promise to be especially revealing.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Phage therapy in clinical practice: treatment of human infections.

              Phage therapy is the application of bacteria-specific viruses with the goal of reducing or eliminating pathogenic or nuisance bacteria. While phage therapy has become a broadly relevant technology, including veterinary, agricultural, and food microbiology applications, it is for the treatment or prevention of human infections that phage therapy first caught the world's imagination--see, especially, Arrowsmith by Sinclair Lewis (1925)--and which today is the primary motivator of the field. Nonetheless, though the first human phage therapy took place in the 1920s, by the 1940s the field, was in steep decline despite early promise. The causes were at least three-fold: insufficient understanding among researchers of basic phage biology; over exuberance, which led, along with ignorance, to carelessness; and the advent of antibiotics, an easier to handle as well as highly powerful category of antibacterials. The decline in phage therapy was neither uniform nor complete, especially in the former Soviet Republic of Georgia, where phage therapy traditions and practice continue to this day. In this review we strive toward three goals: 1. To provide an overview of the potential of phage therapy as a means of treating or preventing human diseases; 2. To explore the phage therapy state of the art as currently practiced by physicians in various pockets of phage therapy activity around the world, including in terms of potential commercialization; and 3. To avert a recapitulation of phage therapy's early decline by outlining good practices in phage therapy practice, experimentation, and, ultimately, commercialization.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS One
                PLoS ONE
                plos
                plosone
                PLoS ONE
                Public Library of Science (San Francisco, CA USA )
                1932-6203
                26 June 2015
                2015
                : 10
                : 6
                : e0130548
                Affiliations
                [1 ]Institute for Integrative Biology of the Cell, CEA, CNRS, Univ Paris-Sud, Université Paris-Saclay, Orsay, France
                [2 ]Laboratoire National de Santé Publique, Abidjan, Côte d’Ivoire
                [3 ]Laboratoire de Bactériologie-Virologie, département de Sciences pharmaceutiques et Biologiques, Univ Félix Houphouët-Boigny, Abidjan, Côte d’Ivoire
                [4 ]Laboratoire de Génétique, Département des Biosciences, Univ Félix Houphouet-Boigny, Abidjan, Côte d’Ivoire
                [5 ]ENSTA ParisTech, Université Paris-Saclay, Palaiseau, France
                Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, POLAND
                Author notes

                Competing Interests: The authors have declared that no competing interests exist.

                Conceived and designed the experiments: GV CP GL SN SL. Performed the experiments: CE LL AC AK CP. Analyzed the data: CE CM YB GV CP. Contributed reagents/materials/analysis tools: CE SL AC AK CP. Wrote the paper: CE GV CP.

                Article
                PONE-D-15-08665
                10.1371/journal.pone.0130548
                4482731
                26115051
                347d0474-786f-4dd1-a52d-c0a0e65eb0c8
                Copyright @ 2015

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

                History
                : 26 February 2015
                : 22 May 2015
                Page count
                Figures: 12, Tables: 3, Pages: 25
                Funding
                Vaincre la Mucoviscidose ( http://www.vaincrelamuco.org/) Agence Nationale de la Recherche ( www.agence-nationale-recherche.fr/) grant number ANR-13-ASTR-0011-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Custom metadata
                The sequences have been deposited to EBI/EMBL: Ab02 LN610572, Ab03 LN610573, Ab05 LN610574, Ab08 LN610575, Ab17 LN610576, Ab18 LN610577, Ab22 LN610578, Ab27 LN610579, 1-15pyo LN610580, Ab04 LN610581, Ab06 LN610582, Ab11 LN610583, Ab19 LN610584, Ab20 LN610585, Ab10 LN610586, Ab15 LN610587, Ab29 LN610588, Ab28 LN610589, Ab30 LN610590.

                Uncategorized
                Uncategorized

                Comments

                Comment on this article